Varicose vein treatment devices market seen topping $2.14 billion by 2030

The market for varicose vein treatment devices is forecast to grow from $1.42 billion in 2025 to $2.14 billion by 2030, driven by more obesity, aging populations and broader use of minimally invasive procedures. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - The market is expanding as more patients seek treatments that can reduce pain, swelling and mobility issues tied to venous insufficiency. - Growth also reflects wider demand for outpatient, minimally invasive procedures that can improve recovery times and patient comfort.

What happened: - The Business Research Company said the global varicose vein treatment devices market reached $1.42 billion in 2025. - The market is projected to rise to $1.54 billion in 2026, representing 8.7% growth. - The market is forecast to reach $2.14 billion by 2030, with an 8.5% CAGR. - The company published the outlook on Sept. 2, 2026, from London. - A free sample of the report is available online. - The full market report is also available.

The details: - Varicose vein treatment devices are medical instruments used to treat swollen, enlarged and twisted veins, most often in the legs. - These devices work by helping improve blood flow when vein valves are weakened or do not function properly. - The market’s recent growth has been supported by more venous insufficiency cases, sedentary lifestyles, demand for cosmetic treatments, an aging population and more specialized clinics. - Future growth is expected to come from wider use of outpatient vein treatments, ablation technologies, ultrasound-guided procedures, minimally invasive options and compression therapy devices. - Endovenous laser ablation, minimally invasive vein closure techniques and non-surgical treatment methods are among the key trends expected to shape the market. - The report says protocols aimed at quicker recovery and improved patient comfort will remain important. - Obesity is a major demand driver because it can increase vein-related complications and reduce mobility. - A World Heart Foundation report in March 2023 said about 2.3 billion adults and children worldwide are obese or overweight. - That figure is projected to rise to 2.7 billion by 2025. - North America held the largest market share in 2025. - Asia-Pacific is expected to record the fastest growth over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast points to a market shifting toward faster, less invasive care outside traditional hospital settings. - The geographic outlook suggests mature adoption in North America and more room for expansion in Asia-Pacific as diagnosis and treatment access broaden. - The obesity link shows how broader public health trends can feed demand for specialized medical devices beyond purely cosmetic use.

What's next: - The market will likely keep moving toward outpatient procedures and minimally invasive technologies through 2030. - The company’s 2026 report set also adds market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards and updated trend graphics. - The Business Research Company also listed contact details for buyers seeking expert guidance and follow-up.